HighTower Advisors’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-43
| Closed | -$3K | – | 2270 |
|
|
2018
Q3 | $3K | Hold |
43
| – | – | ﹤0.01% | 2146 |
|
|
2018
Q2 | $3K | Hold |
43
| – | – | ﹤0.01% | 2100 |
|
|
2018
Q1 | $3K | Sell |
43
-25
| -37% | -$1.74K | ﹤0.01% | 2048 |
|
|
2017
Q4 | $52K | Hold |
68
| – | – | ﹤0.01% | 2074 |
|
|
2017
Q3 | $17K | Hold |
68
| – | – | ﹤0.01% | 2100 |
|
|
2017
Q2 | $15K | Hold |
68
| – | – | ﹤0.01% | 2056 |
|
|
2017
Q1 | $24K | Hold |
68
| – | – | ﹤0.01% | 1941 |
|
|
2016
Q4 | $41K | Sell |
68
-7
| -9% | -$4.22K | ﹤0.01% | 1819 |
|
|
2016
Q3 | $86K | Hold |
75
| – | – | ﹤0.01% | 1748 |
|
|
2016
Q2 | $80K | Hold |
75
| – | – | ﹤0.01% | 1608 |
|
|
2016
Q1 | $94K | Hold |
75
| – | – | ﹤0.01% | 1841 |
|
|
2015
Q4 | $183K | Sell |
75
-4
| -5% | -$9.76K | ﹤0.01% | 1767 |
|
|
2015
Q3 | $91K | Sell |
79
-21
| -21% | -$24.2K | ﹤0.01% | 1739 |
|
|
2015
Q2 | $100K | Buy |
+100
| New | +$100K | ﹤0.01% | 1421 |
|